The final results validate conclusions drawn by Bagli et al. [1], who performed a analyze that involved ten patients diagnosed with CRAO who obtained HBOT. In addition to getting 20 classes of HBOT, oral acetazolamide and topical beta-blockers were administered towards the patients in the earliest probable time.OPDIVO® (nivolumab) can be a prescri